£6.2M
The Series A round was led by Maven VC and Guinness Asset Management to support post-pandemic healthcare recovery.
"As we continue to accelerate and invest in the ethical use of clinical research data to advance new medicines for patient care, this funding gives us the capital needed to carry out our immediate plans while delivering AI solutions which will help futureproof our NHS."
